Abstract:<p>Photodegradation is an important transformation pathway for macrolide antibiotics (MCLs) in aquatic environments, but the ecotoxicity of MCLs after phototransformation has not been reported in detail. This study investigated the effects of roxithromycin (ROX) before and after phototransformation on the growth and physio-biochemical characteristics of Chlorella pyrenoidosa, and its toxicity were explored using transcriptomics analysis. The results showed that 2 mg/L ROX before phototransformation (T0 group) inhibited algae growth with inhibition rates of 53.06%, 54.17%, 47.26%, 31.27%, and 28.38% at 3, 7, 10, 14, and 21 d, respectively, and chlorophyll synthesis was also inhibited. The upregulation of antioxidative enzyme activity levels and the malondialdehyde content indicated that ROX caused oxidative damage to C. pyrenoidosa during 21 d of exposure. After phototransformation for 48 h (T48 group), ROX exhibited no significant impact on the growth and physio-biochemical characteristics of the microalgae. Compared with the control group (without ROX and its phototransformation products), 2010 and 2988 differentially expressed genes were identified in the T0 and T48 treatment groups, respectively. ROX significantly downregulated genes related to porphyrin and chlorophyll metabolism, which resulted in the inhibition of chlorophyll synthesis and algae growth. ROX also significantly downregulated genes of DNA replication, suggesting the increased DNA proliferation risks in algae. After phototransformation, ROX upregulated most of the genes associated with the porphyrin and chlorophyll metabolism pathway, which may be the reason that the chlorophyll content in T48 treatment group showed no significant difference from the control group. Almost all light-harvesting chlorophyll a/b (LHCa/b) gene family members were upregulated in both T0 and T48 treatment groups, which may compensate part of the stress of ROX and its phototransformation products.</p>

pH-dependent geometric isomerization of roxithromycin in simulated gastrointestinal fluids and in rats.

Pharmacokinetics and Metabolism of Jatrorrhizine, A Gastric Prokinetic Drug Candidate

Phototransformation of roxithromycin in the presence of dissolved organic matter: Characteriazation of the degradation products and toxicity evaluation

Transformation of macrolide antibiotics during chlorination process: Kinetics, degradation products, and comprehensive toxicity evaluation

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers

Gastroretentive Delivery Approach to Address pH-Dependent Degradation of (+)- and (-)-Phenserine

Comprehensive Understanding of the Phototransformation Process of Macrolide Antibiotics in Simulated Natural Waters

Physiological, biochemical and transcription effects of roxithromycin before and after phototransformation in Chlorella pyrenoidosa

Transformation of macrolides residues by a novel erythromycin esterase C (Ere C) and safety evaluation of transformed products on Caenorhabditis elegans

Mechanism of Reductive Metabolism and Chiral Inversion of Proton Pump Inhibitors

Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability

Pharmacokinetics of Azalomycin F, a Natural Macrolide Produced by Streptomycete Strains, in Rats

Structural elucidation of 14-membered ring macrolide antibiotics using electrospray ionization tandem mass spectrometry and density functional theory calculations

Handling of computational in vitro/in vivo correlation problems by Microsoft Excel: I. Principles and some general algorithms.

In vitro activity of domestic roxithromycin

Alamethicin: a peptide model for voltage gating and protein-membrane interactions.

Deglycosylated Azithromycin Targets Transgelin to Enhance Intestinal Smooth Muscle Function

Preferential Solvation Study of Rosuvastatin in the {PEG400 (1) + Water (2)} Cosolvent Mixture and GastroPlus Software-Based In Vivo Predictions

Multiorgan Crystal Deposition of an Amphoteric Drug in Rats Due to Lysosomal Accumulation and Conversion to a Poorly Soluble Hydrochloride Salt

Pharmacokinetics and Disposition of Contezolid in Humans—Resolution of a Disproportionate Human Metabolite for Clinical Development

Elucidating a Complicated Enantioselective Metabolic Profile: A Study From Rats to Humans Using Optically Pure Doxazosin